Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
44.29
-3.47 (-7.27%)
At close: Jan 23, 2026, 4:00 PM EST
44.30
+0.01 (0.02%)
After-hours: Jan 23, 2026, 7:44 PM EST
Scholar Rock Holding Employees
Scholar Rock Holding had 128 employees as of December 31, 2024. The number of employees decreased by 22 or -14.67% compared to the previous year.
Employees
128
Change (1Y)
-22
Growth (1Y)
-14.67%
Revenue / Employee
n/a
Profits / Employee
-$2,761,156
Market Cap
4.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 128 | -22 | -14.67% |
| Dec 31, 2023 | 150 | 36 | 31.58% |
| Dec 31, 2022 | 114 | -31 | -21.38% |
| Dec 31, 2021 | 145 | 26 | 21.85% |
| Dec 31, 2020 | 119 | 26 | 27.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Amicus Therapeutics | 499 |
| CRISPR Therapeutics AG | 393 |
| Immunovant | 362 |
| TG Therapeutics | 338 |
| Mirum Pharmaceuticals | 322 |
| Apogee Therapeutics | 196 |
SRRK News
- 7 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 11 days ago - Scholar Rock Holding Corporation (SRRK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 12 days ago - Scholar Rock Highlights 2026 Strategic Priorities - Business Wire
- 18 days ago - Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating - Seeking Alpha
- 19 days ago - Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 7 weeks ago - Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Scholar Rock to Present at Upcoming Investor Conferences - Business Wire
- 2 months ago - Scholar Rock Holding Corporation (SRRK) Q3 2025 Earnings Call Transcript - Seeking Alpha